IL179489A0 - Securing dose quality of inhalable drug - Google Patents

Securing dose quality of inhalable drug

Info

Publication number
IL179489A0
IL179489A0 IL179489A IL17948906A IL179489A0 IL 179489 A0 IL179489 A0 IL 179489A0 IL 179489 A IL179489 A IL 179489A IL 17948906 A IL17948906 A IL 17948906A IL 179489 A0 IL179489 A0 IL 179489A0
Authority
IL
Israel
Prior art keywords
securing
inhalable drug
dose quality
dose
quality
Prior art date
Application number
IL179489A
Original Assignee
Mederio Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401453A external-priority patent/SE528190C2/en
Priority claimed from SE0401612A external-priority patent/SE530006C2/en
Application filed by Mederio Ag filed Critical Mederio Ag
Publication of IL179489A0 publication Critical patent/IL179489A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
IL179489A 2004-06-07 2006-11-22 Securing dose quality of inhalable drug IL179489A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401453A SE528190C2 (en) 2004-06-07 2004-06-07 Inhaler
SE0401612A SE530006C2 (en) 2004-06-18 2004-06-18 Inhaler using tub
PCT/SE2005/000843 WO2005120616A1 (en) 2004-06-07 2005-06-03 Securing dose quality of inhalable drug

Publications (1)

Publication Number Publication Date
IL179489A0 true IL179489A0 (en) 2007-05-15

Family

ID=35502846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179489A IL179489A0 (en) 2004-06-07 2006-11-22 Securing dose quality of inhalable drug

Country Status (10)

Country Link
EP (1) EP1765440A1 (en)
JP (1) JP2008501473A (en)
AU (1) AU2005251670B2 (en)
BR (1) BRPI0511891A (en)
CA (1) CA2569343A1 (en)
IL (1) IL179489A0 (en)
MX (1) MXPA06014265A (en)
NO (1) NO20070053L (en)
RU (1) RU2006145654A (en)
WO (1) WO2005120616A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE385193T1 (en) 2002-03-20 2008-02-15 Mannkind Corp INHALATION DEVICE
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (en) 2004-08-23 2023-01-10 Mannkind Corporation THERAPEUTIC DRY POWDER COMPOSITION CONTAINING DICETOPIPERAZINE, AT LEAST ONE TYPE OF CATION AND ONE BIOLOGICALLY ACTIVE AGENT
DK1937219T3 (en) 2005-09-14 2016-02-15 Mannkind Corp A method for drug formulation based on increasing the affinity of the crystalline surfaces of the microparticle of active principles
IN2015DN00888A (en) 2006-02-22 2015-07-10 Mannkind Corp
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101933816B1 (en) 2008-06-13 2019-03-29 맨카인드 코포레이션 A dry powder inhaler and system for drug delivery
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (en) 2009-11-03 2015-09-24 マンカインド コーポレ−ション Apparatus and method for simulating inhalation activity
RU2531455C2 (en) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Systems and methods for dry powder drugs delivery
JP6133270B2 (en) 2011-04-01 2017-05-24 マンカインド コーポレイション Blister packaging for drug cartridge
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CA2852536A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
ES2624294T3 (en) 2012-07-12 2017-07-13 Mannkind Corporation Dry powder drug delivery systems
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
EP2970149B1 (en) 2013-03-15 2019-08-21 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
BR112016000937A8 (en) 2013-07-18 2021-06-22 Mannkind Corp dry powder pharmaceutical formulations, method for making a dry powder formulation and use of a dry powder pharmaceutical formulation
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP6931952B2 (en) * 2018-10-04 2021-09-08 佳吾 犬飼 Automatic inhaler

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217004A (en) * 1990-12-13 1993-06-08 Tenax Corporation Inhalation actuated dispensing apparatus
ATE139130T1 (en) * 1991-08-16 1996-06-15 Sandoz Ag INHALER FOR ADMINISTRATION OF POWDERED SUBSTANCES
US5415162A (en) * 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
JP3317823B2 (en) * 1995-08-11 2002-08-26 株式会社ユニシアジェックス Dosing device
SE9700424D0 (en) * 1997-02-07 1997-02-07 Astra Ab Powder inhales
ES2228070T3 (en) * 1998-06-22 2005-04-01 Astrazeneca Ab DEVICE FOR VACUUM AND EMPTY CAVES CONTAINING DUST.
SE517229C2 (en) * 2000-09-25 2002-05-14 Microdrug Ag Continuous dry powder inhaler

Also Published As

Publication number Publication date
AU2005251670B2 (en) 2010-04-22
MXPA06014265A (en) 2007-03-12
AU2005251670A1 (en) 2005-12-22
BRPI0511891A (en) 2008-01-15
JP2008501473A (en) 2008-01-24
RU2006145654A (en) 2008-07-20
CA2569343A1 (en) 2005-12-22
NO20070053L (en) 2007-01-03
WO2005120616A1 (en) 2005-12-22
EP1765440A1 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
IL179489A0 (en) Securing dose quality of inhalable drug
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
IL185018A0 (en) Break-resistant delayed-release forms of administration
EP1993518A4 (en) Dosage forms for administering combinations of drugs
IL221103B (en) Inhaler for powdered substances particularly medical substances
EP1749532A4 (en) Drug for remedy or treatment of wound
ZA200610770B (en) Dosage form for delivery of multiple drug forms
HK1109332A1 (en) Transdermal administration of phycotoxins
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
EP1962869A4 (en) Treatment of respiratory diseases
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
PL1740204T3 (en) Medicinal use of alpha-mannosidase
ZA200606637B (en) Means for transdermal administration of nicotine
EP1740541A4 (en) Therapeutic formulations of desoxyepothilones
EP1871344A4 (en) Inhalable drug
EP1791506A4 (en) Methods of device-assisted drug delivery
GB0425532D0 (en) Therapeutic compounds and methods for their preparation and use
IL182322A0 (en) Monitoring of convection enhanced drug delivery
TWI350171B (en) Pharmaceutical compositions for treatment of cardio-cerebral-vascular diseases
GB0404141D0 (en) An alerting inhaler for inhalation therapy
GB0513546D0 (en) Therapeutic compounds and methods for their preparation and use
GB0417474D0 (en) Treatment of respiratory disorders
GB0423245D0 (en) Treatment of breathing disorders
LT1740204T (en) Medicinal use of alpha-mannosidase
IL180185A0 (en) Use of phenylethanolaminotetralines for preparing anxiolytic drugs